A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Obsessive-Compulsive Disorder

In brief

The purpose of this study was to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in participants with Obsessive Compulsive Disorder (OCD).

Key facts

Study ID
NCT04693351
Run by
Biohaven Pharmaceuticals, Inc.
People needed
589
Starts
2021-01-29
Expected to finish
2025-04-29
Last updated by the study team
2026-05-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.